Insider Transactions in Q2 2024 at Syndax Pharmaceuticals Inc (SNDX)
Insider Transaction List (Q2 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 14
2024
|
Keith A. Goldan Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,250
+2.32%
|
$25,000
$20.03 P/Share
|